ICU Medical
ICUI
352 hedge funds and large institutions have $4.47B invested in ICU Medical in 2018 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 133 increasing their positions, 113 reducing their positions, and 39 closing their positions.
102% more call options, than puts
Call options by funds: $33.8M | Put options by funds: $16.7M
28% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 39
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
18% more repeat investments, than reductions
Existing positions increased: 133 | Existing positions reduced: 113
2.53% more ownership
Funds ownership: 74.71% → 77.24% (+2.5%)
2% more funds holding
Funds holding: 344 → 352 (+8)
2% more capital invested
Capital invested by funds: $4.4B → $4.47B (+$72.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$95.1M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$46.5M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$44.9M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$39.9M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$33.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$46M |
| 2 |
Millennium Management
New York
|
-$40.9M |
| 3 |
SAM
Silvercrest Asset Management
New York
|
-$33.7M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$31.3M |
| 5 |
Renaissance Technologies
New York
|
-$30.3M |
ICUI Hedge Fund Activity: Q3 2018 in Review
352 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in ICU Medical (ICUI) for Q3 2018, worth a combined $4.47B — up 1.6% from $4.4B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new ICUI positions and 39 closed out — a net gain of 11 holders — while 133 added to existing stakes and 113 trimmed.
The largest buyer was AQR Capital Management, adding an estimated $95.1M. The largest seller was Champlain Investment Partners, exiting entirely with an estimated $46M sold.
- 352 institutional investors held ICU Medical (ICUI) as of Q3 2018, up from 344 in Q2 2018.
- Funds reported $4.47B of ICU Medical stock for Q3 2018, up 1.6% quarter-over-quarter.
- 50 funds opened new ICU Medical positions in Q3 2018 and 39 closed out, a net change of +11 holders.
- The largest ICU Medical buyer in Q3 2018 was AQR Capital Management, an estimated $95.1M added.
- The largest ICU Medical seller in Q3 2018 was Champlain Investment Partners, an estimated $46M sold.
Based on aggregated 13F filings for Q3 2018.